Short Interest in CSL Limited (OTCMKTS:CSLLY) Drops By 90.9%

CSL Limited (OTCMKTS:CSLLY) was the recipient of a large drop in short interest in the month of November. As of November 15th, there was short interest totalling 1,600 shares, a drop of 90.9% from the October 31st total of 17,500 shares. Based on an average trading volume of 89,900 shares, the days-to-cover ratio is currently 0.0 days.

CSL Stock Performance

CSLLY traded up $0.89 during trading on Thursday, hitting $91.19. The stock had a trading volume of 34,216 shares, compared to its average volume of 35,444. CSL has a 12 month low of $82.55 and a 12 month high of $109.00. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18. The company has a 50 day simple moving average of $96.13 and a 200-day simple moving average of $98.16.

Analyst Ratings Changes

Separately, Macquarie upgraded shares of CSL to a “strong-buy” rating in a report on Tuesday, August 13th.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.